Jan 9, 2018

Democrats grill HHS nominee over drug prices

Alex Azar, President Trump's nominee to lead HHS. Photo: Bill Clark/CQ Roll Call, via Getty Images

Senate Democrats are pressing Alex Azar on the cost of prescription drugs, as the Finance Committee weighs his nomination for Health and Human Services secretary. Sen. Ron Wyden, the committee’s top Democrat, noted that several Eli Lilly drugs saw steep price hikes while Azar ran the company, and asked whether he had ever lowered the price of a product.

“I don’t know that there is any drug price, of a branded product, that has ever gone down — from any company, on any drug, in the United States, because every incentive in this system is toward higher prices,” Azar said, arguing that he could help reshape that system because he knows it well.
  • Value-based contracting — in which drug companies are paid based on how well their products work — “can be vitally important, Azar said, but Medicare’s regulations can “get in the way.”
  • Asked about President Trump's past support for allowing Medicare to negotiate what it will pay for drugs, Azar said the program's prescription drug benefit already has sufficient bargaining tools. But he said he would be open to "looking at" extending those practices into the part of Medicare that covers drugs administered in a doctor's office.

Go deeper

Tech can't remember what to do in a down market

Illustration: Rebecca Zisser/Axios

Wall Street's two-day-old coronavirus crash is a wakeup alarm for Silicon Valley.

The big picture: Tech has been booming for so long the industry barely remembers what a down market feels like — and most companies are ill-prepared for one.

Brace yourself for a coronavirus outbreak

Illustration: Aïda Amer/Axios

Public-health officials’ warnings about the coronavirus are sounding increasingly urgent, with one top CDC official asking the public yesterday "to prepare for the expectation that this might be bad."

Reality check: Other administration officials, including President Trump himself, were more subdued in their assessments. But underneath those tonal differences, the reality of the coronavirus is the same: It spreads quickly, and has already spread to many countries, making it likely to start spreading here, too.

Go deeperArrow53 mins ago - Health

Exclusive: Pro-Trump group plans post-Super Tuesday blitz on Democrats

Democratic presidential hopefuls take the debate stage in South Carolina. Photo: Logan Cyrus/AFP via Getty Images

Pro-Trump super PAC America First Action is preparing to unleash a series of targeted, swing-state attacks on the Democrats most likely to face President Trump after Super Tuesday, people familiar with the group's plans tell me in an exclusive preview of its strategy.

The state of play: The group has been tracking favorable/unfavorable ratings in Florida, Georgia, Michigan, North Carolina, Ohio and Pennsylvania for 2020 candidates Joe Biden, Bernie Sanders, Elizabeth Warren, Pete Buttigieg and Michael Bloomberg — under the theory that if Trump wins each of these six states he would win re-election.